In this online, self-learning activity:
Neonatal respiratory distress syndrome (RDS) occurs in 10.1% of preterm infants born at 34 weeks’ gestational age (GA), corresponding to an over 40-fold increased risk as compared to their 39- to 40-week-GA counterparts. The risk decreases with increasing GA; at a GA of 37 weeks, the risk has fallen to just to just three times that of a full-term infants. Aside from premature birth, risk factors include: maternal gestational diabetes, male infant, and multiplets.
The following healthcare professionals: Neonatologists; physician assistants, nurse practitioners, nurses, and pharmacists who clinically encounter neonatal patients with RSD.
This program is supported by an educational grant from Chiesi.
Learners may participate in this activity free of charge.
Release Date: December 05, 2020 -- Expiration Date: December 05, 2022
Faculty: Jack Sills, MD
Setting the stage
Treating neonatal RDS
By the end of the session the participant will be able to:
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education through ScientiaCME. ScientiaCME is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation: ScientiaCME designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™ toward the AMA Physician's Recognition Award. Physicians should only claim credit commensurate with the extent of their participation in the activity.
ABP MOC Recognition Statement: Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 MOC points in the American Board of Pediatrics's (ABP) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABP MOC credit.
Physicians: For applicable courses, to attain maintenance of certification (MOC) credit, you must enter your board certification ID # and birth date correctly. It is the learner's responsibility to provide this information completely and accurately at the completion of the activity. Without providing it, the learner will NOT receive MOC credit for this activity. Please note: not all activities on this site provide MOC credit. If this activity does not specify that it provides MOC credit in the "Accreditation" section on this page, then it does NOT provide MOC credit.
ScientiaCME is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 1.0 contact hours (0.1 CEUs) of continuing pharmacy education credit. Proof of participation will be posted to your NABP CPE profile within 4 to 6 weeks to participants who have successfully completed the post-test. Participants must participate in the entire presentation and complete the course evaluation to receive continuing pharmacy education credit. ACPE # 0574-0000-20-056-H01-P. ACPE Accreditation effective 12/05/20 expires 12/05/22. This is a Application (A)-type activity.
Pharmacists: You must enter your NABP # and birth date correctly so that proof of participation can be posted to your NABP CPE profile. It is the learner's responsibility to provide this information completely and accurately at the completion of the activity. Without providing it, the learner will NOT receive CPE credit for this activity.
Nurse Practitioners (NPs): The American Academy of Nurse Practitioners accepts AMA PRA Category 1 Credit(s)™ from organizations accredited by the ACCME. ScientiaCME will provide NPs who successfully complete each activity with a certificate of participation indicating that the activity was designated for AMA PRA Category 1 Credit(s)™.
Physician Assistants: The American Academy of Physician Assistants accepts AMA PRA Category 1 Credit(s)™ from organizations accredited by the ACCME.
As a provider of continuing medical education, it is the policy of ScientiaCME to ensure balance, independence, objectivity, and scientific rigor in all of its educational activities. In accordance with this policy, faculty and educational planners must disclose any significant relationships with commercial interests whose products or devices may be mentioned in faculty presentations, and any relationships with the commercial supporter of the activity. The intent of this disclosure is to provide the intended audience with information on which they can make their own judgments. Additionally, in the event a conflict of interest (COI) does exist, it is the policy of ScientiaCME to ensure that the COI is resolved in order to ensure the integrity of the CME activity. For this CME activity, any COI has been resolved thru content review ScientiaCME.
Jack H. Sills, MD, Clinical Professor Pediatrics, University of California, Invine, CA has no relevant conflicts of interest to disclose.
Peer reviewer disclosure:
Rangasamy Ramanathan, MD, discloses that he has received research grant support and consulting honoraria from Cheisi.
Jae Kim, MD, discloses that they have received consulting honoraria from Medela, Nutricia, and Fujifilm; and have stock ownership in Astarte Medical and Nicolette.
Disclosures of Educational Planners: Charles Turck, PharmD, BCPS, BCCCP, CEO of
ScientiaCME, has no relevant conflicts of interest to disclose.
Commercial Support Disclosure: This program is supported by an educational grant from Chiesi.
*Required to view Printable PDF Version
Please take a few minutes to participate in the optional pre-test. It will help us measure the knowledge gained by participating in this activity.